149 related articles for article (PubMed ID: 8985050)
1. The Sievert integral revisited: evaluation and extension to 125I, 169Yb, and 192Ir brachytherapy sources.
Williamson JF
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1239-50. PubMed ID: 8985050
[TBL] [Abstract][Full Text] [Related]
2. Dose rate calculations around 192Ir brachytherapy sources using a Sievert integration model.
Karaiskos P; Angelopoulos A; Baras P; Rozaki-Mavrouli H; Sandilos P; Vlachos L; Sakelliou L
Phys Med Biol; 2000 Feb; 45(2):383-98. PubMed ID: 10701510
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo-based dose-rate tables for the Amersham CDCS.J and 3M model 6500 137Cs tubes.
Williamson JF
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):959-70. PubMed ID: 9652865
[TBL] [Abstract][Full Text] [Related]
4. A comparison of radial dose functions for 103Pd, 125I, 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources.
Meigooni AS; Nath R
Int J Radiat Oncol Biol Phys; 1992; 22(5):1125-30. PubMed ID: 1555964
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
[TBL] [Abstract][Full Text] [Related]
6. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
[TBL] [Abstract][Full Text] [Related]
7. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
Melhus CS; Rivard MJ
Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
[TBL] [Abstract][Full Text] [Related]
8. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
[TBL] [Abstract][Full Text] [Related]
9. Analytical approach to heterogeneity correction factor calculation for brachytherapy.
Daskalov GM; Kirov AS; Williamson JF
Med Phys; 1998 May; 25(5):722-35. PubMed ID: 9608484
[TBL] [Abstract][Full Text] [Related]
10. EGSnrc Monte Carlo calculated dosimetry parameters for 192Ir and 169Yb brachytherapy sources.
Taylor RE; Rogers DW
Med Phys; 2008 Nov; 35(11):4933-44. PubMed ID: 19070227
[TBL] [Abstract][Full Text] [Related]
11. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
Mainegra E; Capote R; López E
Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
[TBL] [Abstract][Full Text] [Related]
12. Radial dose functions for 103Pd, 125I, 169Yb and 192Ir brachytherapy sources: an EGS4 Monte Carlo study.
Mainegra E; Capote R; López E
Phys Med Biol; 2000 Mar; 45(3):703-17. PubMed ID: 10730965
[TBL] [Abstract][Full Text] [Related]
13. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
[TBL] [Abstract][Full Text] [Related]
14. Ytterbium-169: a promising new radionuclide for intravascular brachytherapy.
Patel NS; Fan P; Chiu-Tsao ST; Ravi K; Sherman W; Quon H; Pisch J; Tsao HS; Harrison LB
Cardiovasc Radiat Med; 2001; 2(3):173-80. PubMed ID: 11786324
[TBL] [Abstract][Full Text] [Related]
15. Application of the Monte Carlo integration (MCI) method for calculation of the anisotropy of 192Ir brachytherapy sources.
Baltas D; Giannouli S; Garbi A; Diakonos F; Geramani K; Ioannidis GT; Tsalpatouros A; Uzunoglu N; Kolotas C; Zamboglou N
Phys Med Biol; 1998 Jun; 43(6):1783-801. PubMed ID: 9651040
[TBL] [Abstract][Full Text] [Related]
16. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
[TBL] [Abstract][Full Text] [Related]
17. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
Bannon EA; Yang Y; Rivard MJ
Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
[TBL] [Abstract][Full Text] [Related]
18. On the use of high dose rate 192Ir and 169Yb sources with the MammoSite radiation therapy system.
Papagiannis P; Karaiskos P; Georgiou E; Baltas D; Lymperopoulou G; Pantelis E; Sakelliou L
Med Phys; 2007 Sep; 34(9):3614-9. PubMed ID: 17926965
[TBL] [Abstract][Full Text] [Related]
19. Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy.
Mason DL; Battista JJ; Barnett RB; Porter AT
Med Phys; 1992; 19(3):695-703. PubMed ID: 1508110
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo and analytic calculation of absorbed dose near 137Cs intracavitary sources.
Williamson JF
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):227-37. PubMed ID: 3391820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
